|Articles|January 8, 2019

Turnover Within CRO Companies Remains Persistently High

CRO companies are battling high turnover levels, but a new report from BDO USA, LLP, finds that compensation strategies generally have not made enough adjustments to their compensation strategy to address this on going issue. This report examines compensation and benefits trends in the CRO industry over the last 10 years, with a special focus on clinical research associates.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Turnover Within CRO Companies Remains Persistently High

Related Content

Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection

How to Prevent Continuous Data Review from Just Shifting the Manual Burden

ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access

Artificial Intelligence in Clinical Trials: From Pilots to Practice

What the Industry Needs to Get Right for Real-Time Data Review to Scale

Trending on Applied Clinical Trials Online

Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection

ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access

ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion

FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility

ACT Brief: Data Pipeline Standardization for Real-Time Analysis, Sponsor Accountability Beyond Contracts, and Autoimmune Pipeline Expansion